CD44 and laryngeal carcinoma: To investigate whether CD44 percentage correlates with cisplatin resistance in laryngeal carcinoma; we chose three laryngeal carcinoma cell lines namely, UM-SCC-10B, UM-SCC-15s (the cisplatin resistant pair of UM-SCC-10B) and UM-SCC-74B (Fig 1A).